Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Confluent (CFLT) EBT (2020 - 2025)

Confluent (CFLT) has disclosed EBT for 6 consecutive years, with -$79.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT rose 7.93% year-over-year to -$79.6 million, compared with a TTM value of -$300.7 million through Dec 2025, up 10.15%, and an annual FY2025 reading of -$300.7 million, up 10.15% over the prior year.
  • EBT was -$79.6 million for Q4 2025 at Confluent, down from -$65.0 million in the prior quarter.
  • Across five years, EBT topped out at $358.3 million in Q4 2022 and bottomed at -$150.9 million in Q1 2023.
  • Average EBT over 5 years is -$68.7 million, with a median of -$86.5 million recorded in 2024.
  • The sharpest move saw EBT crashed 287.15% in 2021, then surged 393.82% in 2022.
  • Year by year, EBT stood at -$121.9 million in 2021, then soared by 393.82% to $358.3 million in 2022, then plummeted by 117.56% to -$62.9 million in 2023, then plummeted by 37.5% to -$86.5 million in 2024, then rose by 7.93% to -$79.6 million in 2025.
  • Business Quant data shows EBT for CFLT at -$79.6 million in Q4 2025, -$65.0 million in Q3 2025, and -$75.3 million in Q2 2025.